Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -209,068 | -142,803 | -366,286 | -357,023 | -209,613 |
| Depreciation Amortization | -4,575 | -1,939 | -57 | 1,156 | 1,780 |
| Accounts receivable | 70,519 | 92,638 | -72,059 | -116,814 | -2,254 |
| Accounts payable and accrued liabilities | -17,064 | -13,869 | 8,119 | -12,462 | 5,517 |
| Other Working Capital | -139,546 | -45,520 | -77,260 | -90,246 | -86,568 |
| Other Operating Activity | 29,916 | -38,445 | 200,030 | 235,011 | 59,782 |
| Operating Cash Flow | $-269,818 | $-149,938 | $-307,513 | $-340,378 | $-231,356 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 164,546 | 81,835 | -186,138 | -159,376 | -231,328 |
| PPE Investments | -10,727 | -4,493 | -23,783 | -24,624 | -22,483 |
| Purchase Sale Intangibles | -15,264 | -1,237 | -4,206 | -3,414 | -2,314 |
| Other Investing Activity | -15,264 | -1,237 | -4,206 | -3,414 | -2,314 |
| Investing Cash Flow | $138,555 | $76,105 | $-214,127 | $-187,414 | $-256,125 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -78 | N/A | 575,000 | 575,000 | 575,000 |
| Debt Repayment | N/A | -39 | -488,103 | -488,065 | -433,891 |
| Common Stock Issued | 26,205 | 23,609 | 49,442 | 8,680 | 4,950 |
| Other Financing Activity | 0 | 0 | 507,743 | 507,743 | 489,566 |
| Financing Cash Flow | $26,127 | $23,570 | $644,082 | $603,358 | $635,625 |
| Exchange Rate Effect | -137 | -114 | 352 | 22 | 174 |
| Beginning Cash Position | 399,266 | 399,266 | 276,472 | 276,472 | 276,472 |
| End Cash Position | 293,993 | 348,889 | 399,266 | 352,060 | 424,790 |
| Net Cash Flow | $-105,273 | $-50,377 | $122,794 | $75,588 | $148,318 |
| Free Cash Flow | |||||
| Operating Cash Flow | -269,818 | -149,938 | -307,513 | -340,378 | -231,356 |
| Capital Expenditure | -10,727 | -4,493 | -23,805 | -24,624 | -22,483 |
| Free Cash Flow | -280,545 | -154,431 | -331,318 | -365,002 | -253,839 |